Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRDM4 antisense RNA 1 (PRDM4-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the PRDM4 gene locus[4]. No validated or published data currently defines its molecular function, biological role, or therapeutic relevance, distinguishing it from the protein-coding gene PR domain zinc finger protein 4 (PRDM4), which is a well-studied transcription factor involved in cell cycle regulation, histone methylation, and tumorigenesis[1][2]. There is no indication that PRDM4-AS1 itself serves as a therapeutic target, biomarker, or plays a direct role in any recognized disease process based on current evidence. The entry appears correctly named, but lacks specific functional or clinical data. Key context: - The PRDM4 gene encodes a transcription factor involved in tumor suppression and regulation of neural stem cell fate, but this should not be conflated with PRDM4-AS1[1][2]. - PRDM4-AS1, as an lncRNA, may theoretically participate in regulatory events at the RNA level (such as splicing, stability, or chromatin modification) relevant to the PRDM4 locus, but such roles remain unsubstantiated in public databases or literature as of now[4]. - PRDM4-AS1 is not referenced as a drug target, clinical biomarker, or pathogenic RNA in any curated major database or peer-reviewed study. If you require information on related transcripts such as *PRDM4* or *circPRDM4*, which are implicated in cancer biology, please clarify your query.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRDM4 antisense RNA 1 (PRDM4-AS1).